Home › Funds › Deep Track Capital, LP › IONS
Deep Track Capital, LP position in IONS
IONIS PHARMACEUTICALS INC · Health Care
Deep Track Capital, LP reported holding 2,200,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$174.4M, representing 2.60% of its reported portfolio and ranking #15 among its reported holdings. Deep Track Capital, LP has disclosed IONS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Deep Track Capital, LP's IONS position evolved
Deep Track Capital, LP first disclosed a stake in IONS in Q3 2023 at 2,834,069 shares (US$128.6M). The position peaked in Q3 2025 at 3,808,144 shares, worth US$249.1M. Across 12 filings, Deep Track Capital, LP increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,200,000 shares valued at US$174.4M — an increase of 250,000 shares quarter over quarter.. Notable position changes include a 56% trim in Q4 2023 (shares fell 14% over the following quarter), a 136% increase in Q1 2025 (shares rose 31% over the following quarter), a 55% trim in Q4 2025 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.83M | $128.55M | New |
| Q4 2023 | 1.25M | $63.19M | Reduce |
| Q1 2024 | 1.37M | $59.54M | Add |
| Q2 2024 | 2.00M | $95.32M | Add |
| Q3 2024 | 2.20M | $88.13M | Add |
| Q4 2024 | 1.93M | $67.61M | Reduce |
| Q1 2025 | 4.56M | $137.70M | Add |
| Q2 2025 | 4.89M | $193.26M | Add |
| Q3 2025 | 3.81M | $249.13M | Reduce |
| Q4 2025 | 1.70M | $134.49M | Reduce |
| Q1 2026 | 1.95M | $146.43M | Add |
| Q2 2026 | 2.20M | $174.44M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IONS and 13F data
IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IONS
- Two Sigma Investments 6.25M sh · $495.75M · Q2 2026
- TWO SIGMA ADVISERS, LP 3.05M sh · $241.45M · Q4 2025
- Tweedy, Browne Co LLC 2.28M sh · $180.81M · Q2 2026
- BAKER BROS. ADVISORS LP 2.05M sh · $162.36M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 94.68M sh · $147.77M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 60.00M sh · $93.10M · Q2 2026
- Bellevue Group AG 972.26K sh · $77.09M · Q2 2026
- GROUPAMA ASSET MANAGMENT 937.08K sh · $75.20M · Q2 2026
- Davern Capital Partners, LP 798.71K sh · $63.33M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 787.26K sh · $62.42M · Q2 2026
- Eversept Partners, LP 664.68K sh · $52.70M · Q2 2026
More on Deep Track Capital, LP
FAQ
How long has Deep Track Capital, LP held IONS?
Deep Track Capital, LP has disclosed IONS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Deep Track Capital, LP's current position in IONS?
As of Q2 2026, Deep Track Capital, LP holds 2.20M shares of IONS (IONIS PHARMACEUTICALS INC), valued at $174.44M, representing 2.60% of its reported portfolio and ranking #15.
Has Deep Track Capital, LP been buying or selling IONS?
In the latest 13F filing (Q2 2026), Deep Track Capital, LP increased its position in IONS. The position peaked in Q3 2025 at 3.81M shares.
Which other funds hold IONS?
Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.